Loading...
XHKG
8189
Market cap40mUSD
Jul 08, Last price  
0.15HKD
1D
10.29%
1Q
-47.37%
Jan 2017
-79.73%
IPO
-74.14%
Name

Tianjin TEDA Biomedical Engineering Co Ltd

Chart & Performance

D1W1MN
XHKG:8189 chart
P/E
P/S
0.54
EPS
Div Yield, %
Shrs. gr., 5y
1.88%
Rev. gr., 5y
6.64%
Revenues
509m
+32.15%
270,639,221327,954,880422,511,561432,000,259429,057,203511,150,674677,640,122583,111,851552,041,373501,589,528389,278,236375,906,530351,897,658358,751,734369,355,184476,384,723403,728,831397,998,097385,482,322509,431,694
Net income
-88m
L+218.21%
3,034,418-11,377,409-8,987,6025,148,7796,142,04214,417,02624,017,31721,373,60517,787,42825,564,5125,970,713-13,752,052-177,679,819-88,810,696-47,998,435-42,255,043-27,451,531-20,159,658-27,802,241-88,469,949
CFO
-55m
L+107.76%
1,281,10359,342,567-25,579,7435,975,653-15,921,835-36,261,42728,083,421-10,652,04419,427,774-31,805,169-7,437,03417,399,979-21,840,410-3,798,54035,987,592-6,683,968-12,821,438-13,154,710-26,271,255-54,581,682

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tianjin TEDA Biomedical Engineering Company Limited, founded in 2000 and based in Tianjin, People's Republic of China, is a diversified enterprise primarily involved in the research, development, manufacturing, and distribution of biological compound fertilizer products throughout the PRC. Its operations are organized into two main divisions: Biological Compound Fertilizers and Elderly and Health Care Services. The company's agricultural offerings encompass active fertilizers and various tailored blends of nitrogen, phosphorus, and potassium, specifically formulated to promote balanced growth for a range of crops including grains, fruits, and vegetables. Beyond agriculture, Tianjin TEDA Biomedical provides integrated care for the elderly and comprehensive health services. This includes leasing essential equipment for seniors and offering specialized consulting, advisory, and assessment solutions. Furthermore, the company develops and licenses electroencephalography (EEG) diagnosis detection services, utilizing its expertise in EEG technology for diagnostic applications. Its extensive activities also cover the research, development, production, and practical application of biomedical science and technology projects, alongside regional soil resource conditioning and remediation, and the provision of soil environmental quality standards research services.
IPO date
Jun 18, 2002
Employees
265
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT